MONMOUTH JUNCTION, N.J., (PRNewswire) — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announces the successful completion of its MISSION 100,000 international fundraising campaign to fight the spread of COVID-19, raising $100,000 to benefit the global, not-for-profit humanitarian organization, CARE. The funds raised for CARE’s Crisis Response Campaign enable the organization to provide various vaccination, education, sanitation, and disinfectant initiatives around the world to prevent the spread of COVID-19. CytoSorbents will present CARE its donation at the Opening Bell ceremony at NASDAQ later this morning.
